Macrogenics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.62

-0.24 (-4.94%)

As of Jun 30, 10:32 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 62%

Hold 5 38%

Sell 0 0%

Price Target

Analyst Price Target +849.1% upside

Low Target $27.62

Average Target $43.85

High Target $64.74

Current Price $4.62

Current
$4.62

Target
$43.85

$27.62 $43.85 avg $64.74

Scenario Analysis

Bear Case

$27.62

497.8%

Low target

Base Case

$43.85

+849.1%

Avg target

Bull Case

$64.74

+1,301.3%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$5.08

-9.1% from high

52-Week Low

$1.19

+289.9% from low

Target vs 52W High

$43.85

+763.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%